{"cluster": 69, "subcluster": 43, "abstract_summ": "As SARS-CoV-2 is highly contagious, the risk of infection directly affects the cancer patient being treated, other cancer patients in close proximity, and health care providers.A major consideration in the delivery of cancer care during the pandemic is to balance the risk of patient exposure and infection with the need to provide effective cancer treatment.Proactive management and containment measures, applied in a structured and daily way, has significantly aided the identification of advance patients with suspected symptoms related to COVID-19, limiting their admission to our cancer center; we have thus been more able to protect other patients from possible contamination and at the same time guarantee to the suspected patients the immediate treatment and evaluation in referral hospitals for COVID-19.It has been well documented from the early days of the 2019 novel coronavirus (COVID-19) pandemic that patients with a diagnosis of cancer are not only at higher risks of contracting a COVID-19 infection but also at higher risks of suffering severe, and possibly fatal, outcomes from the infection.Infection at any level for patients or providers can cause significant disruption to even the most effective treatment plans.In particular, lung cancer patients were reported to be at high risk of pulmonary complications related to SARS-CoV2 infection.", "title_summ": "COVID-19 testing in cancer patients: Does one size fit all?Impact of COVID-19 pandemic on lung cancer treatment schedulingEstimating the Risks from COVID-19 Infection in Adult Chemotherapy PatientsSurveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 PandemicLung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology GroupThe COVID-19 Pandemic and its Impact on the Cardio-Oncology PopulationImplications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center HamburgTreatment guidance for lung cancer patients during the COVID-19 pandemicFrequently asked questions regarding SARS-CoV-2 in cancer patients\u2014recommendations for clinicians caring for patients with malignant diseasesImpact of the COVID-19 Outbreak on the Management of Patients with CancerResults of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO ModelPrioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton CenterThe management of surgical patients during the coronavirus dieases 2019 (COVID-19) pandemicHow we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocereVirtual Management of Patients With Cancer During the COVID-19 Pandemic: Web-Based Questionnaire StudyPerspectives of Cancer Patients and Their Health during the COVID-19 PandemicCancer patients and research during COVID-19 pandemic: A systematic review of current evidenceImpact of the COVID-19 pandemic on cancer treatment: the patients\u2019 perspectiveThe impact of COVID-19 pandemic in the colorectal cancer preventionClinical recommendations on lung cancer management during the COVID\u201019 pandemicAmidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread.COVID19 Prevention & Care; A Cancer Specific Guideline.Cancer Care Delivery ChallengesManagement of Lung Cancer During the COVID-19 Pandemic.", "title_abstract_phrases": "As SARS-CoV-2 is highly contagious, the risk of infection directly affects the cancer patient being treated, other cancer patients in close proximity, and health care providers.Conclusions Patients undergoing active treatment for cancer were most concerned about the short-term effects of the COVID-19 pandemic on the logistics as well as potential efficacy of ongoing cancer treatment, longer term effects, and overarching societal concerns that the population at large is not as concerned about the public health implications of the coronavirus.Coronavirus outbreak has affected thousands of people in at least 186 countries which has affected the cancer care delivery system apart from affecting the overall health system.The objective of this study was to compare concerns about COVID-19 among individuals undergoing cancer treatment to those with a history of cancer not currently receiving therapy and to those without a cancer history.Proactive management and containment measures, applied in a structured and daily way, has significantly aided the identification of advance patients with suspected symptoms related to COVID-19, limiting their admission to our cancer center; we have thus been more able to protect other patients from possible contamination and at the same time guarantee to the suspected patients the immediate treatment and evaluation in referral hospitals for COVID-19.Prioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton CenterIt has been well documented from the early days of the 2019 novel coronavirus (COVID-19) pandemic that patients with a diagnosis of cancer are not only at higher risks of contracting a COVID-19 infection but also at higher risks of suffering severe, and possibly fatal, outcomes from the infection."}